4
Changes in Ownership
NewAmsterdam Pharma Co N.V. Filed Acc 0000950170-24-037241
Chief Scientific Officer sold 190,476 shares at $21.50 ($4,095,234)
- Chief Scientific Officer gave up 11,197 shares (to pay taxes)
- Chief Scientific Officer acquired 201,673 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Kastelein Johannes Jacob Pieter · Chief Scientific Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-03-26 | Exercise or conversion : show line 1 in the form | +201,673 | 201,673 | I | ||
| 2024-03-26 | Shares withheld for taxes : show line 2 in the form | −11,197 | $22.72 | $254,396 | 190,476 | I |
| 2024-03-26 | Sale : show line 3 in the form | −190,476 | $21.50 | $4,095,234 | 0 | I |
| Open-market sales · 190,476 sh · avg $21.50 · $4,095,234 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-03-26 | Exercise or conversion : show line 4 in the form Option (right to buy) | −201,673 | 970,229 | I |
Loading xslF345X05/ownership.xml…